Skip to main content

BioLabs Names Cornerstone Partners Boosting Fall Opening of New Durham Facility

Durham-based BioLabs North Carolina is about to become an expanded part of a national network of co-working facilities helping science-based startups go further faster with limited capital investment.

NCBiotech Company Directory Is New – and Free -- Again

The price is right – free -- and the content is rich. It’s the newly published 2017-18 print edition of the NCBiotech Company Directory.

Aug. 14 New Application Deadline for Pitching Investors at SEBIO Forum

Privately owned life science companies looking for funding still have a few days to apply for a chance to pitch their stories to potential investors and partners at the 2017 SEBIO Investor and Partnering Forum in Pinehurst this fall.

Avista Pharma Hired to Make Clinical Supplies of Opioid Addiction Vaccine

Durham-based Avista Pharma Solutions has been tapped by a Minneapolis research organization to manufacture an important component of a vaccine to combat opioid addiction.

Innovate Seeks Orphan Drug Status for Ulcerative Colitis Therapy

Innovate Biopharmaceuticals, a clinical-stage biotechnology company based in Raleigh, has submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for an oral therapy to treat pediatric ulcerative colitis.

Viamet Gets Fast Track Status for Valley Fever Therapy

Durham-based Viamet Pharmaceuticals has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its anti-fungal agent VT-1598, a novel oral therapy for the treatment of valley fever.

Genova Quietly Grows Precision Health Reach from Asheville HQ

For more than 30 years, Genova Diagnostics has been quietly growing its clinical laboratory services from its headquarters in Asheville, evolving into the significant new world of precision health services.

PhRMA Reports Cite NC, NCBiotech Leadership Amid Global Competition

A series of new reports by the Pharmaceutical Research and Manufacturers of America (PhRMA) highlight North Carolina’s position as a top state in the nation for driving innovation and economic growth for the 21st Century through efforts to attract and grow the biopharmaceutical industry amid an increasingly competitive global environment.

Bullish on Ag Tech, Alexandria Creating R&D ‘Mega Campus’ in RTP

Already a major landlord in the Research Triangle Park, California-based Alexandria Real Estate Equities is developing a unique multi-tenant research and development campus in the Research Triangle Park to drive North Carolina’s global leadership in agricultural biotechnology.

Liver Cell Therapy Developed in Durham Accepted for Canadian Review

A cell-based therapy developed in Durham for a rare liver disease in newborns has been accepted for regulatory review in Canada.


Subscribe to RSS - Business & Commercialization